Fetoscopic Repair of Isolated Fetal Spina Bifida
NCT: NCT03090633 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this investigation is to evaluate maternal and fetal outcomes following fetoscopic repair of fetal spina bifida at the Johns Hopkins Hospital. The hypothesis of this study is that fetoscopic spina bifida repair is feasible and has the same effectiveness as open repair of fetal spina bifida, but with the benefit of significantly lower maternal and fetal complication rates. The fetal benefit of the procedure will be the prenatal repair of spina bifida. The maternal benefit of fetoscopic spina bifida repair will be the avoidance of a large uterine incision. This type of incision increases the risk of uterine rupture and requires that all future deliveries are by cesarean section. The use of the minimally invasive fetoscopic surgical technique may also lower the risk of preterm premature rupture of membranes and preterm birth compared to open fetal surgery. Finally, successful fetoscopic spina bifida repair also makes vaginal delivery possible.
Frequently Asked Questions
What is Fetoscopic Repair of Isolated Fetal Spina Bifida?
Fetoscopic Repair of Isolated Fetal Spina Bifida is a clinical trial registered under NCT03090633. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03090633?
The current status of NCT03090633 (Fetoscopic Repair of Isolated Fetal Spina Bifida) is: ACTIVE_NOT_RECRUITING.
When did Fetoscopic Repair of Isolated Fetal Spina Bifida start?
Fetoscopic Repair of Isolated Fetal Spina Bifida started on 2017-05-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.